SSB
KITE

Sandy Spring Bank’s Kite Pharma, Inc. KITE Stock Holding History

Sandy Spring Bank’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,100
Closed -$198K – 901
2017
Q3 		$198K Hold
1,100
– – 0.02% 285
2017
Q2 		$114K Hold
1,100
– – 0.01% 342
2017
Q1 		$86K Hold
1,100
– – 0.01% 373
2016
Q4 		$49K Buy
+1,100
New +$54K 0.01% 445

Sandy Spring Bank's KITE Position: Q4 2017 in Review

Sandy Spring Bank sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,100 shares — an estimated $198K sold.

Sandy Spring Bank first reported a position in KITE in Q4 2016 and held it in 4 quarters. The position peaked at $198K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Sandy Spring Bank reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Sandy Spring Bank sold 1,100 Kite Pharma, Inc. shares in Q4 2017, an estimated $198K.
  • Sandy Spring Bank first reported a position in Kite Pharma, Inc. in Q4 2016 and held it in 4 quarters.
  • Sandy Spring Bank's Kite Pharma, Inc. position peaked at $198K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Sandy Spring Bank's 13F filing for Q4 2017, filed 2 Feb 2018.